Agenda

Congress Agenda

The 7th Congress of Hematologists of Serbia will feature lectures by leading experts, panel discussions, workshops, and interactive sessions. The program is designed to provide participants with the latest scientific insights, practical experience, and opportunities for professional development.

The program will combine specialized topics with networking and discussion opportunities, facilitating the exchange of knowledge and ideas across various fields of hematology.

7 Reasons Why Participation Matters

• The program will support the development of hematology in Serbia

• Participants will enhance their professional and scientific competencies

• Opportunities for networking among healthcare professionals and industry

• Latest therapies and technologies will be presented

• The program will support young researchers and specialists

• Strengthening partnerships in the healthcare sector

• Participants will gain brand promotion and visibility among leading experts

DAY 1

DAY 2

DAY 3

AGENDA

DAY 1Thursday, October 22, 2026

HALL 1

11.00–12.00

SATELLITE SYMPOSIUM

12.15–13.15

SATELLITE SYMPOSIUM · NOVARTIS

Expert Lecture: Unlocking the Clinical and Therapeutic Value of Scemblix – A Comparative Perspective vs. Other TKI Therapies, Integrating Evidence from Clinical Trials and Real-World Experience — Prof. dr Dragana Milojković
Expert Panel Discussion: Identifying the Ideal Patient for Scemblix Therapy? Translating Evidence into Everyday Clinical Decision-Making

Panelists: Prof. dr Andrija Bogdanović, Prof. dr Ivana Urošević, Doc. dr Danijela Leković

13.30–14.30LUNCH

14.30–15.30

PLENARY LECTURE

NHL low grade

Lecturer: Prof. dr Marco Ladetto

15.45–16.45

SATELLITE SYMPOSIUM · TAKEDA

Choosing first-line therapy for HL: when A+AVD, and when BrECADD?

Panelists: Prof. dr Predrag Đurđević, Ass. dr Marija Elez

17.00–17.45

EDUCATIONAL SESSION

Stem cell transplantation as a therapeutic challenge

Moderators: Prof. dr Milena Todorović Balint, Ass. dr Marija Elez, Prof. dr Aleksandar Savić

18.00–18.45

SATELLITE SYMPOSIUM · ASTRAZENECA

A step beyond the standard in PNH: the power of the danicopan–ravulizumab combination

Moderators: Prof. dr Andrija Bogdanović, Doc. dr Mirjana Mitrović

1. Dual complement inhibition in PNH therapy: from biological concept to clinical application — Prof. dr Andrija Bogdanović
2. From concept to practice: first experiences with danicopan in patients with PNH — Doc. dr Mirjana Mitrović

19.00–20.00CONGRESS OPENING AND WELCOME COCKTAIL

HALL 2

11.00–12.00

EDUCATIONAL SESSION

Ph-negative MPN

Moderators: Prof. dr Andrija Bogdanović, Doc. dr Danijela Leković, Prof. dr Ivana Urošević

1. Treatment of blast transformation in MPN — Prof. dr Andrija Bogdanović
2. The role of PEG-IFN in the modern treatment of MPN — Prof. dr Ivana Urošević
3. New treatment targets in polycythemia vera: the role of clonal and inflammatory pathways — Doc. dr Danijela Leković

12.15–13.15

SATELLITE SYMPOSIUM

13.30–14.30LUNCH

14.30–15.30

EDUCATIONAL SESSION

Hematopoietic stem cell disorders

Moderators: Prof. dr Aleksandar Savić, Doc. dr Marijana Virijević, Doc. dr Nenad Govedarović

1. Aplastic anemia: a current approach to diagnosis and treatment — Doc. dr Marijana Virijević
2. Diagnosis of myelodysplastic syndrome in 2026 — Prof. dr Andrija Bogdanović
3. How to treat patients with myelodysplastic syndrome? — Prof. dr Aleksandar Savić

15.45–16.45

EDUCATIONAL SESSION

Acute lymphoblastic leukemia

Moderators: Prof. dr Ana Vidović, Prof. dr Aleksandar Savić, Doc. dr Irena Đunić

1. The role of NGS in the molecular diagnostics of ALL — Dr Marija Denčić Fekete
2. Advances in the treatment of ALL patients — Doc. dr Borivoj Sekulić
3. The role of immunotherapy in the treatment of ALL patients — Prof. dr Milena Todorović Balint

17.00–18.00

EDUCATIONAL SESSION

Sherlock Holmes: “Differential diagnosis of hematologic diseases – a workshop through clinical cases”

Moderators: Prof. dr Ivana Urošević, Prof. dr Andrija Bogdanović

1. “Diagnosis in the fog: a case that defies logic” — Prof. dr Ivanka Perčić
2. “Fertility in the shadow of a rare disease” — Dr Isidora Arsenović
3. “Traces in the shadow of anemia: a diagnostic enigma” — Prof. dr Marina Dokić
4. “Skin changes with an unexpected background” — Dr Nikola Lemajić
5. “Hidden in plain sight: navigating the fog of orbital infiltrates” — Dr Mihailo Smiljanić

DAY 2Friday, October 23, 2026

HALL 1

09.00–09.45

EDUCATIONAL SESSION

Acute myeloid leukemia

Moderators: Prof. dr Ana Vidović, Doc. dr Borivoj Sekulić, Prof. dr Miodrag Vučić

1. Diagnosis and classification of AML — Dr Ljubomir Jaković
2. The role of NGS in molecular diagnosis and risk stratification of acute myeloid leukemia — Prof. dr Ana Vidović
3. A new therapeutic approach for “fit” AML patients — Prof. dr Nada Suvajdžić Vuković
4. Modern treatment of “unfit” AML patients — Doc. dr Marijana Virijević

10.00–11.00

SATELLITE SYMPOSIUM · ROCHE 1

DLBCL across lines of therapy: from 1L to the R/R approach

10.00–10.05Introduction and clinical framework: first-line DLBCL challenges in Serbia
10.05–10.25Pushing the boundaries in first-line (1L) DLBCL: European recommendations and clinical evidence
10.25–10.45Modern management of relapsed and refractory disease (R/R DLBCL) — Prof. Marco Ladetto (Italy)
10.45–11.00Interactive discussion and Q&A: choosing the optimal therapeutic path — Prof. dr Marco Ladetto (all participants)

11.15–12.15

SATELLITE SYMPOSIUM

12.30–13.30

SATELLITE SYMPOSIUM · EUPHARM 1

Beyond the First Generation: The Next Era of BTK Inhibition Across B-Cell Malignancies

1. Beyond the First Generation: A New Era of BTK Inhibition in CLL — Prof. dr Othman Al Sawaf (Germany)
2. Reimagining BTK Inhibition in WM: Efficacy, Safety, and Beyond — Prof. dr Jelena Bila
3. From Limited Options to New Possibilities: BTK Inhibition in MZL
4. Panel discussion and closing

13.30–14.30LUNCH

14.30–15.30

EDUCATIONAL SESSION

Immunodeficiency-associated lymphoproliferative disorders

Moderators: Doc. dr Olivera Marković, Doc. dr Zorica Cvetković, Doc. dr Lavinika Atanasković

15.45–16.30

EDUCATIONAL SESSION

Crossroad of hemostasis and lymphoproliferative diseases

Moderators: Prof. dr Predrag Miljić and Prof. dr Darko Antić

16.45–17.45

EDUCATIONAL SESSION

Benign hematology – thrombocytopenias

Moderators: Prof. dr Nada Suvajdžić, Doc. dr Mirjana Mitrović, Prof. dr Svetlana Đukić

1. Pathophysiology of ITP and novel drugs — Prof. dr Nada Suvajdžić
2. Thrombosis in ITP — Prof. dr Svetlana Đukić
3. New guidelines — Doc. dr Mirjana Mitrović

18.00–19.00

EDUCATIONAL SESSION

Consultative hematology

Moderators: Doc. dr Mirjana Mitrović, Prof. dr Irena Ćojbašić, Ass. dr Snežana Sretenović

1. Heparin-induced thrombocytopenia — Doc. dr Mirjana Mitrović
2. How I diagnose and treat a patient with eosinophilia — Prof. dr Andrija Bogdanović
3. Coagulopathy in the critically ill — Ass. dr Jelena Bodrožić

HALL 2

09.00–09.45

SATELLITE SYMPOSIUM · MEDICOPHARMACIA

Invasive fungal infections: “Invasive aspergillosis or invasive zygomycosis – precise diagnosis leads to successful treatment of hematology patients”

Moderators: Prof. dr Ana Vidović, Prim. dr Snežana Jovanović

1. Differential diagnosis between invasive aspergillosis and invasive zygomycosis — Prim. dr Snežana Jovanović
2. Therapeutic approach to invasive aspergillosis and invasive zygomycosis — Prof. dr Ana Vidović

10.00–11.00

EDUCATIONAL SESSION

The first 100 years of von Willebrand disease

Moderators: Prof. dr Predrag Miljić, Prof. dr Miodrag Vučić

1. Challenges in managing inherited bleeding disorders in women — Prof. dr Predrag Miljić
2. Diagnostics of von Willebrand disease — Prof. dr Irena Zupan (Ljubljana)
3. Advances in the therapy of von Willebrand disease — Prof. dr Miodrag Vučić

11.15–12.00

SATELLITE SYMPOSIUM · GENESIS

New perspectives in the targeted therapy of hematologic malignancies

Moderators: Prof. dr Svetlana Đukić, Prof. dr Olivera Marković

1. Ponatinib in the treatment of CML: from resistance to an optimal molecular response — Prof. dr Svetlana Đukić
2. The place of tafasitamab in treating patients with R/R DLBCL and FL in clinical practice — Prof. dr Olivera Marković

12.15–13.15

EDUCATIONAL SESSION

Guideline presentation – National Good Clinical Practice Guideline: thromboprophylaxis and treatment of venous thromboembolism in patients with malignancy

Moderator: Prof. dr Darko Antić

Panelists: Doc. dr Mirjana Mitrović, Dr Nikica Sabljić, Dr Nikola Pantić, Dr Vladimir Otašević (Parexel)

13.30–14.30LUNCH

14.30–15.15

SATELLITE SYMPOSIUM · PFIZER

Moderator: Prof. dr Predrag Miljić

1. MDR Gram-negative infections in hematology patients – clinical challenges and therapeutic options — Ass. dr Marija Elez
2. New horizons in the treatment of people with hemophilia — Prof. dr Predrag Miljić
3. Discussion

15.30–16.15

EDUCATIONAL SESSION

PET/CT in hematology

Moderators: Asist. dr Vojin Vuković, Doc. dr Strahinja Odalović (PET Center UCCS)

FOYER

16.30–18.30

Poster session

Moderators: Doc. dr Danijela Agić, Doc. dr Ivan Tijanić, Dr sci. med. Predrag Krstić

DAY 3Saturday, October 24, 2026

HALL 1

09.00–09.45

EDUCATIONAL LECTURE

Prothrombin Belgrade – back to the future

Moderators: Prof. dr Predrag Miljić, Prof. dr Miodrag Vučić, Dr Nebojša Rajić

1. Prothrombin Belgrade – 10 years later — Prof. dr Predrag Miljić
2. Lectures on new gene mutations and mechanisms of antithrombin resistance — lecturers from the Institute of Human Genetics and Genetic Engineering, Belgrade (TBD)

10.00–11.00

SATELLITE SYMPOSIUM · ROCHE 2

More than bleeding: a new perspective on life with hemophilia

Participants: Prof. dr Predrag Miljić, Prof. dr Ivana Urošević, Prof. dr Miodrag Vučić, Prof. dr Predrag Đurđević

10.00–10.15A new paradigm of success in hemophilia A treatment: why has quality of life become our primary therapeutic goal? — Prof. dr Predrag Miljić (UKCS)
10.15–10.50Panel – National Hematology Forum – real-world perspectives: how the transformation of care is changing daily life for adult patients with hemophilia A — Prof. dr Predrag Miljić (moderator), Prof. dr Ivana Urošević, Prof. dr Predrag Đurđević, Prof. dr Miodrag Vučić
10.50–11.00Q&A and consensus for the future — Prof. dr Predrag Miljić (moderator), Prof. dr Ivana Urošević, Prof. dr Predrag Đurđević, Prof. dr Miodrag Vučić

11.15–12.00

Oral presentations

Moderators: Doc. dr Marijana Virijević, Prof. dr Goran Marjanović, Prof. dr Ivanka Perčić

12.15–13.30

EDUCATIONAL SESSION

The many faces of plasma cell dyscrasias

Moderators: Doc. dr Danijela Jovanović, Prof. dr Irena Ćojbašić, Prof. dr Jelena Bila

1. MGUS or MGCS – modern diagnostics and therapeutic approach — Asist. dr Aleksandra Sretenović
2. Is amyloidosis one disease or many? — Prof. dr Irena Ćojbašić
3. Plasma cell leukemia — Doc. dr Danijela Jovanović
4. Waldenström macroglobulinemia — Asist. dr Nada Vlaisavljević
5. Multiple myeloma: prevention and management of adverse effects of novel immunotherapies — Prof. dr Jelena Bila
6. Panel discussion

13.30–14.30LUNCH

14.30–16.15

Nurses’ Session 1

16.30–17.00CONGRESS CLOSING

HALL 2

09.00–10.00

EDUCATIONAL SESSION

Experimental hematology

Moderators: Prof. dr Vladimir Jurišić, Prof. dr Goran Marjanović, Doc. dr Željko Todorović

1. In vitro investigation of cytokine effects on hematopoietic cell lines — Prof. dr Vladimir Jurišić
2. Bone marrow adipose tissue: its role in the regulation of hematopoiesis and in hematologic malignancies — Drenka Trivanović, Mirjana Čučaković, Marko Vujačić, Marijana Kovačić, Aleksandra Jauković
3. Immunomodulatory properties of Galectin-1 and its applicability as a biomarker in hematology — Prof. dr Goran Marjanović
4. Analysis of relative BIRC3 gene expression in patients with chronic lymphocytic leukemia — Stanislava Nikolić, Iva Barjaktarović, Maša Sladojević, Tanja Šašić Ostojić, Borivoj Sekulić, Ivanka Perčić, Danijela Agić

10.15–12.00

EDUCATIONAL SESSION

Laboratory procedures in hematology

Moderators: Prof. dr Andrija Bogdanović, Doc. dr Danijela Jovanović

1. Detection of the leukemic immunophenotype and minimal residual disease in patients with acute leukemias — N. Kraguljac et al.
2. The place of progenitor cultures in the modern classification of myeloproliferative neoplasms — D. Šefer et al.
3. Detection of FLT3 gene mutations (ITD and TKD) and their assessment in patients with AML — V. Đorđević et al.
4. The complexity of diagnosing immune-mediated bone marrow damage through the model of pure red cell aplasia (PRCA) — Bogdanović et al.
5. Next-generation sequencing (NGS) in the diagnosis and prognosis of patients with hematologic neoplasms — M. Denčić Fekete et al.
Round table: where does hematologic diagnostics in Serbia stand – experiences from all centers — lecturers, moderators, all participants

12.15–13.30

EDUCATIONAL SESSION

Drug interactions in the treatment of hematology patients

Moderators: Prof. dr Dragan Milovanović, Asist. dr Marija Elez, Dr sci. med. Dijana Šefer

1. “Clinically significant interactions among newer drugs in hematology” — Dr sci. med. Dijana Šefer
2. “Practical and research aspects of identifying and analyzing drug interactions in hematology” — Prof. dr Dejana Ružić Zečević, Mr ph. Vladimir Vučetić
3. “Safe therapy in hematopoietic stem cell transplantation: managing drug interactions in practice” — Asist. dr Marija Elez
4. Discussion

13.30–14.30LUNCH

14.30–15.45

Oral presentations

Moderators: Prof. dr Nataša Čolović, Prof. dr Milica Radojković, Doc. dr Ivan Tijanić

FOYER

15.00–16.15

Poster session

Moderators: Doc. dr Zorica Cvetković, Dr Mila Purić